UK markets open in 1 hour 57 minutes
NIKKEI 225
38,795.99 +559.92 (+1.46%) HANG SENG
18,420.38 -157.92 (-0.85%) CRUDE OIL
78.61 +0.13 (+0.17%) GOLD FUTURES
2,331.20 0.00 (0.00%) DOW
38,852.27 +176.59 (+0.46%) Bitcoin GBP
50,533.94 -570.66 (-1.12%)
Enanta Pharmaceuticals, Inc. (9EP.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 09:55PM CEST
| Previous close | 13.90 |
| Open | 14.00 |
| Bid | 13.30 x 15600 |
| Ask | 13.80 x 15300 |
| Day's range | 13.30 - 14.00 |
| 52-week range | 7.50 - 25.60 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 286.929M |
| Beta (5Y monthly) | 0.49 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Enanta Pharmaceuticals Reports Fiscal Q2 Results: A Closer Look Against Analyst Expectations
Comparative Analysis Reveals Mixed Financial Outcomes
- Zacks
Enanta Pharmaceuticals (ENTA) Reports Q2 Loss, Tops Revenue Estimates
Enanta Pharmaceuticals (ENTA) delivered earnings and revenue surprises of -16.67% and 3.55%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
Strong week for Enanta Pharmaceuticals (NASDAQ:ENTA) shareholders doesn't alleviate pain of five-year loss
While it may not be enough for some shareholders, we think it is good to see the Enanta Pharmaceuticals, Inc...
© 2024 Yahoo. All rights reserved.